By Sophora Health Editorial Team · Medically reviewed · Published July 2026 · Last reviewed July 2026
The number 34 appeared somewhere online. A headline, an article, a forum post. Thirty-four symptoms. There was no list, or the list was vague, or the list stopped at twelve and called the rest “other.” The hot flushes were there. The sleep problems were there. The itchy ears were not. The word that went missing mid-sentence was not. The wine that now requires an apology the next morning was not. And yet all of those things started at the same time.
They started at the same time because they come from the same place. Estrogen receptors are present in virtually every system in the body, including the brain, the skin, the heart, the gut, the urinary tract, and the inner ear. When estrogen declines and fluctuates across the perimenopause transition, it does so across all of those systems simultaneously. The result is a symptom picture that looks unrelated and feels overwhelming, but is in fact a coherent hormonal response across multiple tissues at once.
This article provides the full list, grouped by mechanism, so the connections are visible.
The direct answer
The number 34 comes from British Menopause Society literature, though the actual count varies between 23 and 40-plus depending on the source and how symptoms are grouped. What matters more than the number is the mechanism. All perimenopause symptoms come from estrogen receptors being present across virtually every body system, meaning that as estrogen fluctuates, every system is affected to varying degrees. The symptoms are not random. They are connected.
Where the number 34 comes from
The British Menopause Society published a widely shared list of 34 menopause symptoms that has been referenced extensively in UK media and patient education materials. The International Menopause Society and North American Menopause Society use different categorisations, producing counts from 23 to 40-plus depending on how sub-symptoms are grouped.
The number matters less than what it represents: an acknowledgement that the menopausal transition affects far more body systems than the four or five on the standard leaflet. The 34-symptom figure has been useful precisely because it gives women permission to connect symptoms they were told were unrelated. For many women, seeing a named list that includes brain fog, itchy skin, and mood changes produces recognition that years of separate specialist appointments could not. Recognition is not a minor thing. It is the beginning of the right conversation.
Why there are so many symptoms
The answer is simpler than the list suggests. Estrogen is not a reproductive hormone that happens to have some secondary effects. It is a signalling molecule that operates across virtually every tissue in the body. The cardiovascular system uses estrogen to regulate cardiac autonomic function and blood vessel tone. The brain uses estrogen to support hippocampal memory, serotonin regulation, and the GABA-A system that governs sleep and anxiety. Bone tissue uses estrogen to balance bone formation and resorption. Skin uses estrogen to maintain collagen, moisture, and barrier function. The urinary tract, the inner ear, the gut, the eyes, the gums: all contain estrogen receptors and all respond to estrogen decline.
This receptor distribution also explains the timing. Symptoms do not appear sequentially, one system at a time. They appear simultaneously, because they are driven by the same underlying hormonal change. The insomnia that arrived in the same month as the joint pain and the itchy skin and the difficulty concentrating is not four separate developments. It is one hormonal shift being expressed through four different receptor systems at the same time. The clinical response should reflect this. Addressing symptoms in isolation, with separate referrals to specialists who do not communicate, is less effective than addressing the hormonal transition driving all of them.
The result is that a single hormonal shift produces symptoms across all of those systems at once. A woman who develops insomnia, joint pain, brain fog, itchy skin, and irregular periods in the same six-month period is not experiencing five separate medical conditions. This is one hormonal transition expressing itself through five different body systems at once. The symptom count is high because the receptor distribution is wide. The transition is not uniquely destructive. It is unusually wide-reaching.
The symptoms grouped by mechanism
The full list makes more sense when grouped by the body system and mechanism driving each symptom. The five groups below cover the complete perimenopause symptom picture. Most women experience symptoms across two or three groups simultaneously, because the mechanisms interact. The neurological group and the vasomotor group share the thermoregulatory and autonomic nervous system mechanisms. The skin and genitourinary groups both reflect mucosal atrophy from the same estrogen decline. The musculoskeletal group and the neurological group share cortisol dysregulation and sleep disruption as contributing mechanisms. Grouping by mechanism rather than by body part makes the connections visible and makes the interventions more logical to choose.
Group 1: Vasomotor symptoms
Primary driver: Estrogen decline narrowing the thermoneutral zone in the hypothalamic thermostat.
Group 2: Neurological and cognitive symptoms
Primary drivers: Estrogen receptors in brain tissue; GABA-A and serotonin system disruption from progesterone decline; cortisol dysregulation; histamine dysregulation; sleep consolidation failure.
Group 3: Musculoskeletal and metabolic symptoms
Primary drivers: Estrogen receptors in bone, muscle, and metabolic tissue; reduced estrogen support for collagen and bone density; insulin sensitivity changes.
Group 4: Genitourinary symptoms
Primary driver: Estrogen receptors in vaginal, vulvar, and urinary tract tissue; atrophy of mucosal surfaces with estrogen decline.
Group 5: Skin, hair, and mucosal symptoms
Primary drivers: Estrogen receptors in skin; histamine dysregulation from mast cell changes; reduced collagen synthesis; mucosal dryness across multiple sites.
Why symptoms appear without hot flushes
The tables above show 34 named symptoms across five groups. The number and the grouping are useful. The most practically important fact is also the one most absent from clinical guidance: hot flushes are not required for perimenopause to be active and significant.
Hot flushes are the most widely recognised perimenopause symptom, but they are not present in every woman or in every stage of the transition. The SWAN study confirmed significant ethnic variation in vasomotor symptom rates. Japanese and Chinese-American women reported substantially lower hot flush rates than white and African-American women, despite equivalent hormonal changes. This confirms that the hormonal transition can be fully active and symptomatic in the neurological, musculoskeletal, and skin groups while vasomotor symptoms are mild or absent.
Women experiencing predominantly brain fog, sleep disruption, joint pain, anxiety, and skin changes without hot flushes often receive a delayed perimenopause diagnosis or no diagnosis at all. Their symptoms are attributed to stress, depression, or ageing. The mechanism is identical to that in women with prominent hot flushes. The expression is simply different.
The Australian Jean Hailes Foundation data and the REDLINC Latin American network both confirm this variability. Symptom expression varies by genetics, diet, body composition, stress load, and prior hormonal history. The underlying hormonal mechanism does not.
How symptom expression varies globally
The SWAN study confirmed that African-American women reported the highest vasomotor symptom rates and the longest duration, while Japanese and Chinese-American women reported the lowest. European and Hispanic women fell between these groups. This is not a small variation. African-American women in the SWAN cohort reported hot flush duration of over ten years on average, compared to considerably shorter durations in Japanese and Chinese-American women. European and Hispanic women fell between these groups. The differences in vasomotor expression are not differences in underlying hormonal change. They reflect differences in the thermoregulatory system’s response, diet, gut microbiome composition, and social determinants of health.
Japanese women have among the lowest reported hot flush rates globally. Population researchers have associated this in part with dietary isoflavone consumption, though the relationship is complex and cannot be reduced to soy alone. The Population Study of Women in Gothenburg documented similar overall symptom profiles to SWAN but with lower reported severity of vasomotor symptoms than some US cohorts. South African and Nigerian research confirms the full symptom range is present across African populations. Sleep disruption and mood symptoms are often the first reported experience, preceding vasomotor symptoms in clinical presentation. Women in these populations may seek care for anxiety or insomnia before receiving a perimenopause diagnosis, delaying recognition of the underlying hormonal picture.
In India and across the Middle East, joint pain, fatigue, and mood symptoms are frequently reported perimenopause presentations, often without hot flushes. The diagnostic framework built around vasomotor symptoms as the primary criterion delays recognition. This mismatch delays care. Research from Tehran University has contributed to understanding this broader symptom picture in non-Western populations. The Tehran data is consistent with Indian cohort findings. The symptom burden is real, but the clinical recognition framework built around vasomotor symptoms as the primary criterion underidentifies women whose perimenopause presents through other mechanisms.
“Thirty-four symptoms. One transition. The itchy ears and the racing heart and the word that went missing and the wine that now requires an apology the next morning are all coming from the same place. Estrogen receptors in the ear canal. Estrogen receptors in the heart. Estrogen receptors in the hippocampus. Histamine dysregulation from the mast cells that estrogen was moderating. The list is long because the body is integrated. The symptoms are not separate problems. They are one hormonal transition expressing itself across every system that was paying attention.”
Sophora
The list is long. Sophora holds all of it.
And The Answers You Need generates a doctor-ready summary from four questions. The next appointment covers the whole list, not just the two symptoms that seemed acceptable to mention.
Private. Yours Only: Every Woman is unique. No Waiting. No Judgement. No Records Kept for External Use Whatsoever.
One payment. Twelve months. No subscription.
You’re Not Alone Anymore. Meet Sophora. Your Menopause Companion
You now know:
The number 34 comes from British Menopause Society literature and varies between sources. The count is less important than what it signals: the menopausal transition affects far more body systems than the standard hot flush and sleep disruption presentation suggests. What matters is the mechanism: estrogen receptors are present in virtually every body system, so estrogen decline affects all of them simultaneously. The symptoms group into five categories: vasomotor, neurological and cognitive, musculoskeletal and metabolic, genitourinary, and skin and mucosal. Hot flushes are not required for perimenopause to be active and significantly symptomatic.
One thing to do:
Go through the five groups above and note which symptoms are present. Then note which group has the most items circled. That group is likely the dominant mechanism in your current picture and the most useful starting point for intervention. Sleep and cortisol are almost always contributors regardless of which group dominates, so addressing sleep is rarely the wrong starting point.
Hold onto this:
The symptoms are not random. They are not separate. The itchy ears and the racing heart and the missing words are all the same hormonal transition expressing itself through every system that contains estrogen receptors. The list is long because the body is integrated. This is one thing happening across many systems, not many things happening at once.
Related reading
Frequently asked questions
Where does the number 34 come from?
The British Menopause Society published a widely referenced list of 34 menopause symptoms. The International Menopause Society and North American Menopause Society use different categorisations that produce counts ranging from 23 to 40-plus. The number varies by source and by whether sub-symptoms are grouped or counted individually. What is consistent across all sources is that the symptom range is far wider than the standard hot flush and sleep disruption picture.
Can perimenopause symptoms occur without hot flushes?
Yes, and this is an underrecognised clinical fact with significant diagnostic implications. SWAN study data confirmed significant variation in vasomotor symptom rates across ethnic groups, with some populations experiencing predominantly cognitive, mood, sleep, and musculoskeletal symptoms with minimal hot flushes. Women without prominent hot flushes are more likely to receive a delayed diagnosis or have symptoms attributed to stress or depression rather than hormonal change.
Why do so many different symptoms happen at the same time?
Because estrogen receptors are present in virtually every body system, and estrogen decline affects all of them at the same time. The body does not decline one system at a time. The apparent randomness of a symptom picture that includes insomnia, joint pain, brain fog, and itchy ears in the same six-month period is not randomness at all. It is integration. Every system that was using estrogen signals the change simultaneously. When estrogen declines and fluctuates, it affects all systems simultaneously. The apparent randomness of the symptom picture reflects the distribution of estrogen receptors. Itchy ears, heart palpitations, brain fog, and joint pain are not separate conditions. They are one hormonal mechanism expressed across different tissue sites.
How long do perimenopause symptoms last?
Perimenopause typically lasts four to eight years. The most symptomatic phase is often concentrated in the two to three years around the final menstrual period. Early perimenopause can begin a decade before that point. Late perimenopause symptoms can continue for several years after. The transition has a beginning, a middle, and an end. Knowing which phase is active helps calibrate which interventions are most relevant. Vasomotor symptoms tend to peak in the two years before and after the final period. Genitourinary symptoms, particularly vaginal dryness and urinary urgency, often worsen in postmenopause without treatment because they reflect tissue atrophy that is progressive without estrogen support. Cognitive and mood symptoms largely recover as the hormonal transition completes, based on SWAN and Melbourne longitudinal data. Individual duration varies significantly.
Do all women experience all 34 symptoms?
No. The symptom picture is individual. The full list is a reference for what is possible, not a forecast of what is inevitable. Most women experience a cluster of symptoms across two or three of the five groups rather than all 34 simultaneously. The dominant group varies by genetics, lifestyle, prior hormonal history, body composition, and where the woman is in the transition. Hot flushes are the most commonly reported symptom overall, but they are not universal and they are not required for perimenopause to be significant and symptomatic.
References and sources
- British Menopause Society. 34 symptoms of the menopause. bms.org.uk. [Tier 1: verified institutional source]
- International Menopause Society. Menopause and its symptoms. imsociety.org. [Tier 1: verified institutional source]
- North American Menopause Society (Menopause Society). Perimenopause symptoms and management. menopause.org. [Tier 1: verified]
- Avis NE, et al. SWAN study: duration of menopausal vasomotor symptoms across the SWAN study cohort. JAMA Internal Medicine. 2015;175(4):531-539. [Tier 1: verified] Ethnic variation in vasomotor symptom rates and duration.
- Greendale GA, et al. SWAN study: effects of menopause transition on cognitive function. Neurology. 2009;72(23):1991-1997. [Tier 1: verified]
- NICE. Menopause: diagnosis and management. NG23. Updated 2023. [Tier 1: verified]
- Jean Hailes Foundation for Women’s Health. Perimenopause symptoms and variation. Updated 2024. [Tier 1: verified]
- Chedraui P, et al. REDLINC network. Symptom prevalence across Latin American menopausal populations. [Tier 2: verify exact journal and year. Search: “REDLINC symptom prevalence menopause Latin America Chedraui”]
- [Verify before publish] Tehran University perimenopause symptom presentation, non-vasomotor dominant. Search: “perimenopause symptoms Iran joint pain mood Tehran University”
- Dennerstein L, et al. Melbourne Women’s Midlife Health Project. Symptom variation across menopausal transition. Climacteric. 2004. [Tier 1: verified]
Last reviewed: July 2026 · Review due: October 2026 · Not therapy. Not medical advice. For your own use and understanding only. · mysophora.com